InspireMD registers $36.83 million of stock for convertible units sale

Bookrunner Dawson James will sell convertible preferreds with warrants

By Devika Patel

Knoxville, Tenn., April 14 – InspireMD, Inc. will conduct a public sale of convertible preferred units with a greenshoe, according to an S-1 filed Thursday with the Securities and Exchange Commission. The company has registered up to $36,829,688 of stock.

The units will each consist of one series B convertible preferred share and one five-year warrant.

The 0% preferreds may each be converted to 1,000 common shares.

Dawson James Securities, Inc. is the bookrunner and may participate.

Proceeds will be used for operations and general working capital requirements, to conduct sales activities, to develop new products and for general corporate purposes.

InspireMD is a medical device company based in Boston.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.